Leonard Khirug (CSO) presents Skinvivo service offering for cosmetic product development with an emphasis on the newly developed readout — measuring advanced glycation end-products (AGE) in the skin of human volunteers.
The lecture features Neurotar’s proprietary Mobile HomeCage device, which enables imaging in awake and freely moving animals. Leonard Khiroug (CSO) shares the experiences of using the device for in vivo two-photon imaging and maps out other application areas.
Slush is the largest start-up conference in Northern Europe and Russia. It is held in Helsinki. This year, 1000 companies and 500 investors are expected to participate. To schedule a meeting with Neurotar’s CEO, Katja Karelina, please follow this link https://meetin.gs/meet/katja-karelina1 or send a direct mail through the contact page.
Neurotar team comes to San Diego for partnering and client meeting in the Bay area. The team attends Society for Neuroscience meeting with an aim of promoting the Mobile HomeCage, Neurotar’s proprietary research device for imaging in awake and freely moving mice. The device is due to be launched before the end of the year. […] Read more »
Neurotar first entered the market for research services in cosmetics in 2012. Since then, our cosmetics service offering (Skinvivo services) has grown far beyond the original best-sellers, repetitive high resolution measurements of changes in collagen’s and elastin’s amounts and fine structure in the living human skin. We have since developed readouts for measuring the redox […] Read more »
On July 16, 2013, the US Patent and Trademark Office granted a patent for Neurotar’s mobile platform (Mobile HomeCage) for awake animal imaging (US 8,485,133). EU patent is pending. Neurotar’s scientists continue to work with the current prototype to optimize services, which will be available to our customers at the end of 2013. Development of two […] Read more »
Neurotar’s SCO, Leonard Khirug, attends Eurotox congress in Interlaken, Switzerland, on Spetember 1.-3., 2013 to promote Neurotar’s new safety assessment assay for CNS and non-CNS drugs.
Leonard Khiroug, CSO of Neurotar, presents as part of the panel discussion on Strategies for CNS Drug and Device Development. Neurotech Summit comes to Helsinki for the second time in 2013. This established US event for companies active in the field of neuroscience was successfully launched in Europe in 2011. It is a must for […] Read more »
IVM is the only event entirely dedicated to in vivo two-photon (a.k.a. multiphoton) imaging. This year, we have extended the coverage from CNS and immunology to human skin imaging and data analysis. Registration is open until the 26th of May, 2013. Follow this link to the event’s website: http://www.neurotar.com/ivm2013/program-2013/ Welcome! Please contact us if you are interested in […] Read more »